Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 240 participants.
Also called NCT04982419
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 2/3
- Enrolled
- 240 participants
- Registry
-
NCT04982419
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT04982419. Randomized; single masking; primary purpose prevention. Start 2021-11-01 (actual); primary completion 2028-03-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
- Acronym
- RICH
- Condition
- Acute Kidney Injury
- Condition
- Heart Failure
- Condition
- Contrast Induced Nephropathy
- Condition
- Coronary Angiography
- Condition
- Percutaneous Coronary Intervention
- Intervention (Device)
- Remote ischemic preconditioning
- Intervention (Device)
- Sham remote ischemic conditioning
- Lead sponsor
- VA Office of Research and Development
Record details
- Record id
cardio:ct-nct04982419- Content hash
a1b40c746dc0f3abfdc879903ee4b0c2791bd9954eb642dd6ceff9dc39e42022